BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zeilinger K, Freyer N, Damm G, Seehofer D, Knöspel F. Cell sources for in vitro human liver cell culture models. Exp Biol Med (Maywood) 2016;241:1684-98. [PMID: 27385595 DOI: 10.1177/1535370216657448] [Cited by in Crossref: 74] [Cited by in F6Publishing: 76] [Article Influence: 12.3] [Reference Citation Analysis]
Number Citing Articles
1 Zschiesche A, Chundela Z, Thieme D, Keiler AM. HepG2 as promising cell-based model for biosynthesis of long-term metabolites: Exemplified for metandienone. Drug Test Anal 2021. [PMID: 34705329 DOI: 10.1002/dta.3184] [Reference Citation Analysis]
2 Alwahsh SM, Rashidi H, Hay DC. Liver cell therapy: is this the end of the beginning? Cell Mol Life Sci. 2018;75:1307-1324. [PMID: 29181772 DOI: 10.1007/s00018-017-2713-8] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
3 Francisco V, Rebelo C, Rodrigues AF, Blersch J, Fernandes H, Ferreira L. A high-throughput screening platform to identify nanocarriers for efficient delivery of RNA-based therapies. Methods 2021;190:13-25. [PMID: 33359052 DOI: 10.1016/j.ymeth.2020.12.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Willemse J, Lieshout R, van der Laan LJ, Verstegen MM. From organoids to organs: Bioengineering liver grafts from hepatic stem cells and matrix. Best Practice & Research Clinical Gastroenterology 2017;31:151-9. [DOI: 10.1016/j.bpg.2017.03.003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
5 Gijbels E, Vilas-Boas V, Deferm N, Devisscher L, Jaeschke H, Annaert P, Vinken M. Mechanisms and in vitro models of drug-induced cholestasis. Arch Toxicol 2019;93:1169-86. [PMID: 30972450 DOI: 10.1007/s00204-019-02437-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
6 Kuna L, Bozic I, Kizivat T, Bojanic K, Mrso M, Kralj E, Smolic R, Wu GY, Smolic M. Models of Drug Induced Liver Injury (DILI) - Current Issues and Future Perspectives. Curr Drug Metab 2018;19:830-8. [PMID: 29788883 DOI: 10.2174/1389200219666180523095355] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 8.8] [Reference Citation Analysis]
7 Vishwakarma SK, Lakkireddy C, Bardia A, Paspala SAB, Tripura C, Habeeb MA, Khan AA. Bioengineered functional humanized livers: An emerging supportive modality to bridge the gap of organ transplantation for management of end-stage liver diseases. World J Hepatol 2018; 10(11): 822-836 [PMID: 30533183 DOI: 10.4254/wjh.v10.i11.822] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Nikolic M, Sustersic T, Filipovic N. In vitro Models and On-Chip Systems: Biomaterial Interaction Studies With Tissues Generated Using Lung Epithelial and Liver Metabolic Cell Lines. Front Bioeng Biotechnol 2018;6:120. [PMID: 30234106 DOI: 10.3389/fbioe.2018.00120] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
9 Seo JE, Tryndyak V, Wu Q, Dreval K, Pogribny I, Bryant M, Zhou T, Robison TW, Mei N, Guo X. Quantitative comparison of in vitro genotoxicity between metabolically competent HepaRG cells and HepG2 cells using the high-throughput high-content CometChip assay. Arch Toxicol 2019;93:1433-48. [PMID: 30788552 DOI: 10.1007/s00204-019-02406-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
10 Fisher J, Sørensen OE, Abu-Humaidan AHA. Using chemiluminescence imaging of cells (CLIC) for relative protein quantification. Sci Rep 2020;10:18280. [PMID: 33106566 DOI: 10.1038/s41598-020-75208-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Nie X, Liang Z, Li K, Yu H, Huang Y, Ye L, Yang Y. Novel organoid model in drug screening: Past, present, and future. Liver Research 2021;5:72-8. [DOI: 10.1016/j.livres.2021.05.003] [Reference Citation Analysis]
12 Li Y, Lu YY, Jia J, Fang M, Zhao L, Jiang Y, Shi Y, Tu PF, Guo XY. A Novel System for Evaluating the Inhibition Effect of Drugs on Cytochrome P450 Enzymes in vitro Based on Human-Induced Hepatocytes (hiHeps). Front Pharmacol 2021;12:748658. [PMID: 34776966 DOI: 10.3389/fphar.2021.748658] [Reference Citation Analysis]
13 Ruoß M, Häussling V, Schügner F, Olde Damink LHH, Lee SML, Ge L, Ehnert S, Nussler AK. A Standardized Collagen-Based Scaffold Improves Human Hepatocyte Shipment and Allows Metabolic Studies over 10 Days. Bioengineering (Basel) 2018;5:E86. [PMID: 30332824 DOI: 10.3390/bioengineering5040086] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
14 Bovard D, Iskandar A, Luettich K, Hoeng J, Peitsch MC. Organs-on-a-chip: A new paradigm for toxicological assessment and preclinical drug development. Toxicology Research and Application 2017;1:239784731772635. [DOI: 10.1177/2397847317726351] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Brovold M, Keller D, Devarasetty M, Dominijanni A, Shirwaiker R, Soker S. Biofabricated 3D in vitro model of fibrosis-induced abnormal hepatoblast/biliary progenitors' expansion of the developing liver. Bioeng Transl Med 2021;6:e10207. [PMID: 34589593 DOI: 10.1002/btm2.10207] [Reference Citation Analysis]
16 Liu Z, Zhu L, Thakkar S, Roberts R, Tong W. Can Transcriptomic Profiles from Cancer Cell Lines Be Used for Toxicity Assessment? Chem Res Toxicol 2020;33:271-80. [DOI: 10.1021/acs.chemrestox.9b00288] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
17 Romualdo GR, Leroy K, Costa CJS, Prata GB, Vanderborght B, da Silva TC, Barbisan LF, Andraus W, Devisscher L, Câmara NOS, Vinken M, Cogliati B. In Vivo and In Vitro Models of Hepatocellular Carcinoma: Current Strategies for Translational Modeling. Cancers (Basel) 2021;13:5583. [PMID: 34771745 DOI: 10.3390/cancers13215583] [Reference Citation Analysis]
18 Hendriks DFG, Hurrell T, Riede J, van der Horst M, Tuovinen S, Ingelman-sundberg M. Mechanisms of Chronic Fialuridine Hepatotoxicity as Revealed in Primary Human Hepatocyte Spheroids. Toxicological Sciences 2019;171:385-95. [DOI: 10.1093/toxsci/kfz195] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
19 Ribeiro AJS, Yang X, Patel V, Madabushi R, Strauss DG. Liver Microphysiological Systems for Predicting and Evaluating Drug Effects. Clin Pharmacol Ther 2019;106:139-47. [PMID: 30993668 DOI: 10.1002/cpt.1458] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
20 Lee MO, Lee SG, Jung CR, Son YS, Ryu JW, Jung KB, Ahn JH, Oh JH, Lee HA, Lim JH, Kim J, Jang I, Choi J, Jung J, Park K, Lee B, Kim DS, Son MY, Cho HS. Development of a quantitative prediction algorithm for target organ-specific similarity of human pluripotent stem cell-derived organoids and cells. Nat Commun 2021;12:4492. [PMID: 34301945 DOI: 10.1038/s41467-021-24746-w] [Reference Citation Analysis]
21 Ferrari E, Rasponi M. Liver-Heart on chip models for drug safety. APL Bioeng 2021;5:031505. [PMID: 34286172 DOI: 10.1063/5.0048986] [Reference Citation Analysis]
22 Wang H, Brown PC, Chow ECY, Ewart L, Ferguson SS, Fitzpatrick S, Freedman BS, Guo GL, Hedrich W, Heyward S, Hickman J, Isoherranen N, Li AP, Liu Q, Mumenthaler SM, Polli J, Proctor WR, Ribeiro A, Wang JY, Wange RL, Huang SM. 3D cell culture models: Drug pharmacokinetics, safety assessment, and regulatory consideration. Clin Transl Sci 2021. [PMID: 33982436 DOI: 10.1111/cts.13066] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
23 Patel JC, Parveen S. In Vitro and In Vivo Analysis of Fentanyl and Fentalog Metabolites using Hyphenated Chromatographic Techniques: A Review. Chem Res Toxicol 2021. [PMID: 34957817 DOI: 10.1021/acs.chemrestox.1c00225] [Reference Citation Analysis]
24 Brito E, Gomes E, Falé PL, Borges C, Pacheco R, Teixeira V, Machuqueiro M, Ascensão L, Serralheiro MLM. Bioactivities of decoctions from Plectranthus species related to their traditional use on the treatment of digestive problems and alcohol intoxication. Journal of Ethnopharmacology 2018;220:147-54. [DOI: 10.1016/j.jep.2018.04.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
25 Dame K, Ribeiro AJ. Microengineered systems with iPSC-derived cardiac and hepatic cells to evaluate drug adverse effects. Exp Biol Med (Maywood) 2021;246:317-31. [PMID: 32938227 DOI: 10.1177/1535370220959598] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Collins SD, Yuen G, Tu T, Budzinska MA, Spring K, Bryant K, Shackel NA; Gastoenterology and Liver Laboratory, Ingham Institute for Applied Medical Research, Liverpool, New South Wales, Australia, South Western Sydney Clinical School, University of New South Wales, Sydney, Australia, Gastoenterology and Liver Laboratory, Ingham Institute for Applied Medical Research, Liverpool, New South Wales, Australia, South Western Sydney Clinical School, University of New South Wales, Sydney, Australia, Department of Molecular Virology, University Hospital Heidelberg, Heidelberg, Germany, German Center for Infection Research (DZIF), Heidelberg Partner Site, Heidelberg, Germany, Gastoenterology and Liver Laboratory, Ingham Institute for Applied Medical Research, Liverpool, New South Wales, Australia, Medical Oncology Group, Ingham Institute for Applied Medical Research, Liverpool, Australia, Liverpool Clinical School, Western Sydney University, Liverpool, Australia, Medical Oncology Group, Ingham Institute for Applied Medical Research, Liverpool, Australia, Liverpool Clinical School, Western Sydney University, Liverpool, Australia, Gastoenterology and Liver Laboratory, Ingham Institute for Applied Medical Research, Liverpool, New South Wales, Australia, South Western Sydney Clinical School, University of New South Wales, Sydney, Australia, Gastoenterology and Liver Laboratory, Ingham Institute for Applied Medical Research, Liverpool, New South Wales, Australia, South Western Sydney Clinical School, University of New South Wales, Sydney, Australia. In Vitro Models of the Liver: Disease Modeling, Drug Discovery and Clinical Applications. In: Tirnitz-parker JE, editor. Hepatocellular Carcinoma. Codon Publications; 2019. pp. 47-67. [DOI: 10.15586/hepatocellularcarcinoma.2019.ch3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
27 Han B, Mo H, Svarovskaia E, Mateo R. A primary human hepatocyte/hepatic stellate cell co-culture system for improved in vitro HBV replication. Virology 2021;559:40-5. [PMID: 33813211 DOI: 10.1016/j.virol.2021.03.012] [Reference Citation Analysis]
28 Serras AS, Rodrigues JS, Cipriano M, Rodrigues AV, Oliveira NG, Miranda JP. A Critical Perspective on 3D Liver Models for Drug Metabolism and Toxicology Studies. Front Cell Dev Biol 2021;9:626805. [PMID: 33732695 DOI: 10.3389/fcell.2021.626805] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
29 Kanabekova P, Kadyrova A, Kulsharova G. Microfluidic Organ-on-a-Chip Devices for Liver Disease Modeling In Vitro. Micromachines 2022;13:428. [DOI: 10.3390/mi13030428] [Reference Citation Analysis]
30 Ruoß M, Rebholz S, Weimer M, Grom-Baumgarten C, Athanasopulu K, Kemkemer R, Käß H, Ehnert S, Nussler AK. Development of Scaffolds with Adjusted Stiffness for Mimicking Disease-Related Alterations of Liver Rigidity. J Funct Biomater 2020;11:E17. [PMID: 32183326 DOI: 10.3390/jfb11010017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Milojević M, Rožanc J, Vajda J, Činč Ćurić L, Paradiž E, Stožer A, Maver U, Vihar B. In Vitro Disease Models of the Endocrine Pancreas. Biomedicines 2021;9:1415. [PMID: 34680532 DOI: 10.3390/biomedicines9101415] [Reference Citation Analysis]
32 Ye J, Chen J. Interferon and Hepatitis B: Current and Future Perspectives. Front Immunol 2021;12:733364. [PMID: 34557195 DOI: 10.3389/fimmu.2021.733364] [Reference Citation Analysis]
33 Llewellyn SV, Niemeijer M, Nymark P, Moné MJ, van de Water B, Conway GE, Jenkins GJS, Doak SH. In Vitro Three-Dimensional Liver Models for Nanomaterial DNA Damage Assessment. Small 2021;17:e2006055. [PMID: 33448117 DOI: 10.1002/smll.202006055] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
34 Sphabmixay P, Raredon MSB, Wang AJ, Lee H, Hammond PT, Fang NX, Griffith LG. High resolution stereolithography fabrication of perfusable scaffolds to enable long-term meso-scale hepatic culture for disease modeling. Biofabrication 2021;13. [PMID: 34479229 DOI: 10.1088/1758-5090/ac23aa] [Reference Citation Analysis]
35 Liu Q, Cai J, Nichols RG, Tian Y, Zhang J, Smith PB, Wang Y, Yan C, Patterson AD. A Quantitative HILIC-MS/MS Assay of the Metabolic Response of Huh-7 Cells Exposed to 2,3,7,8-Tetrachlorodibenzo-p-Dioxin. Metabolites 2019;9:E118. [PMID: 31226775 DOI: 10.3390/metabo9060118] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
36 Buick JK, Williams A, Meier MJ, Swartz CD, Recio L, Gagné R, Ferguson SS, Engelward BP, Yauk CL. A Modern Genotoxicity Testing Paradigm: Integration of the High-Throughput CometChip® and the TGx-DDI Transcriptomic Biomarker in Human HepaRG™ Cell Cultures. Front Public Health 2021;9:694834. [PMID: 34485225 DOI: 10.3389/fpubh.2021.694834] [Reference Citation Analysis]
37 Liu JT, Lamprecht MP, Duncan SA. Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery. J Vis Exp 2018. [PMID: 29863663 DOI: 10.3791/57194] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
38 Yao T, Zhang Y, Lv M, Zang G, Ng SS, Chen X. Advances in 3D cell culture for liver preclinical studies. Acta Biochim Biophys Sin (Shanghai) 2021;53:643-51. [PMID: 33973620 DOI: 10.1093/abbs/gmab046] [Reference Citation Analysis]
39 Cao D, Ge JY, Wang Y, Oda T, Zheng YW. Hepatitis B virus infection modeling using multi-cellular organoids derived from human induced pluripotent stem cells. World J Gastroenterol 2021; 27(29): 4784-4801 [PMID: 34447226 DOI: 10.3748/wjg.v27.i29.4784] [Reference Citation Analysis]
40 Chen L, Yang Y, Ueno H, Esch MB. Body-in-a-Cube: a microphysiological system for multi-tissue co-culture with near-physiological amounts of blood surrogate. Microphysiol Syst 2020;4. [PMID: 34131641 DOI: 10.21037/mps-19-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
41 Kang SH, Kim MY, Eom YW, Baik SK. Mesenchymal Stem Cells for the Treatment of Liver Disease: Present and Perspectives. Gut Liver 2020;14:306-15. [PMID: 31581387 DOI: 10.5009/gnl18412] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
42 Basu A, Dydowiczová A, Čtveráčková L, Jaša L, Trosko JE, Bláha L, Babica P. Assessment of Hepatotoxic Potential of Cyanobacterial Toxins Using 3D In Vitro Model of Adult Human Liver Stem Cells. Environ Sci Technol 2018;52:10078-88. [PMID: 30059226 DOI: 10.1021/acs.est.8b02291] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
43 Xie Y, Yao J, Jin W, Ren L, Li X. Induction and Maturation of Hepatocyte-Like Cells In Vitro: Focus on Technological Advances and Challenges. Front Cell Dev Biol 2021;9:765980. [PMID: 34901010 DOI: 10.3389/fcell.2021.765980] [Reference Citation Analysis]
44 Zhang J, Yun S, Du Y, Zannettino A, Zhang H. Hydrogel-based preparation of cell aggregates for biomedical applications. Applied Materials Today 2020;20:100747. [DOI: 10.1016/j.apmt.2020.100747] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
45 Nobakht Lahrood F, Saheli M, Farzaneh Z, Taheri P, Dorraj M, Baharvand H, Vosough M, Piryaei A. Generation of Transplantable Three-Dimensional Hepatic-Patch to Improve the Functionality of Hepatic Cells In Vitro and In Vivo. Stem Cells Dev 2020;29:301-13. [PMID: 31856676 DOI: 10.1089/scd.2019.0130] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
46 Ishida Y, Yamasaki C, Iwanari H, Yamashita H, Ogawa Y, Yanagi A, Furukawa S, Kojima Y, Chayama K, Kamiie J, Tateno C. Detection of acute toxicity of aflatoxin B1 to human hepatocytes in vitro and in vivo using chimeric mice with humanized livers. PLoS One 2020;15:e0239540. [PMID: 32966316 DOI: 10.1371/journal.pone.0239540] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
47 Li JY, Wang LL, Fan J, Liu DX, Han JB, Zhang YF, Yin DD, Yi YX. New and effective method to develop primary hepatocytes from liver cancer patients. Exp Biol Med (Maywood) 2022;:15353702221085534. [PMID: 35470702 DOI: 10.1177/15353702221085534] [Reference Citation Analysis]
48 Yan L, Messner CJ, Tian M, Gou X, Suter-Dick L, Zhang X. Evaluation of dioxin induced transcriptomic responses in a 3D human liver microtissue model. Environ Res 2022;:112906. [PMID: 35181307 DOI: 10.1016/j.envres.2022.112906] [Reference Citation Analysis]
49 Rogal J, Zbinden A, Schenke-Layland K, Loskill P. Stem-cell based organ-on-a-chip models for diabetes research. Adv Drug Deliv Rev 2019;140:101-28. [PMID: 30359630 DOI: 10.1016/j.addr.2018.10.010] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
50 Waldherr M, Mišík M, Ferk F, Tomc J, Žegura B, Filipič M, Mikulits W, Mai S, Haas O, Huber WW, Haslinger E, Knasmüller S. Use of HuH6 and other human-derived hepatoma lines for the detection of genotoxins: a new hope for laboratory animals? Arch Toxicol 2018;92:921-34. [PMID: 29218508 DOI: 10.1007/s00204-017-2109-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
51 Soret PA, Magusto J, Housset C, Gautheron J. In Vitro and In Vivo Models of Non-Alcoholic Fatty Liver Disease: A Critical Appraisal. J Clin Med 2020;10:E36. [PMID: 33374435 DOI: 10.3390/jcm10010036] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
52 Al-Dhamin Z, Liu LD, Li DD, Zhang SY, Dong SM, Nan YM. Therapeutic efficiency of bone marrow-derived mesenchymal stem cells for liver fibrosis: A systematic review of in vivo studies. World J Gastroenterol 2020; 26(47): 7444-7469 [PMID: 33384547 DOI: 10.3748/wjg.v26.i47.7444] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
53 Brooks A, Liang X, Zhang Y, Zhao CX, Roberts MS, Wang H, Zhang L, Crawford DHG. Liver organoid as a 3D in vitro model for drug validation and toxicity assessment. Pharmacol Res 2021;169:105608. [PMID: 33852961 DOI: 10.1016/j.phrs.2021.105608] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
54 Ouchi R, Togo S, Kimura M, Shinozawa T, Koido M, Koike H, Thompson W, Karns RA, Mayhew CN, McGrath PS, McCauley HA, Zhang RR, Lewis K, Hakozaki S, Ferguson A, Saiki N, Yoneyama Y, Takeuchi I, Mabuchi Y, Akazawa C, Yoshikawa HY, Wells JM, Takebe T. Modeling Steatohepatitis in Humans with Pluripotent Stem Cell-Derived Organoids. Cell Metab. 2019;30:374-384.e6. [PMID: 31155493 DOI: 10.1016/j.cmet.2019.05.007] [Cited by in Crossref: 111] [Cited by in F6Publishing: 107] [Article Influence: 37.0] [Reference Citation Analysis]
55 Park E, Kim HK, Jee J, Hahn S, Jeong S, Yoo J. Development of organoid-based drug metabolism model. Toxicology and Applied Pharmacology 2019;385:114790. [DOI: 10.1016/j.taap.2019.114790] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
56 Mirahmad M, Sabourian R, Mahdavi M, Larijani B, Safavi M. In vitro cell-based models of drug-induced hepatotoxicity screening: progress and limitation. Drug Metab Rev 2022;:1-76. [PMID: 35403528 DOI: 10.1080/03602532.2022.2064487] [Reference Citation Analysis]
57 Kumar S, Curran JE, Williams-Blangero S, Blangero J. Efficient Generation of Functional Hepatocytes from Human Induced Pluripotent Stem Cells for Disease Modeling and Disease Gene Discovery. Methods Mol Biol 2021. [PMID: 33772461 DOI: 10.1007/7651_2021_375] [Reference Citation Analysis]
58 Basu A, Dydowiczová A, Trosko JE, Bláha L, Babica P. Ready to go 3D? A semi-automated protocol for microwell spheroid arrays to increase scalability and throughput of 3D cell culture testing. Toxicol Mech Methods 2020;30:590-604. [PMID: 32713235 DOI: 10.1080/15376516.2020.1800881] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
59 Perera D, Soysa P, Wijeratne S. A Comparison of Mesenchymal Stem Cell-derived Hepatocyte-like Cells and HepG2 Cells for Use in Drug-Induced Liver Injury Studies. Altern Lab Anim. [DOI: 10.1177/02611929221091269] [Reference Citation Analysis]
60 Müller FA, Sturla SJ. Human in vitro models of nonalcoholic fatty liver disease. Current Opinion in Toxicology 2019;16:9-16. [DOI: 10.1016/j.cotox.2019.03.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 9] [Article Influence: 8.3] [Reference Citation Analysis]
61 Rombaut M, Boeckmans J, Rodrigues RM, van Grunsven LA, Vanhaecke T, De Kock J. Direct reprogramming of somatic cells into induced hepatocytes: Cracking the Enigma code. J Hepatol 2021;75:690-705. [PMID: 33989701 DOI: 10.1016/j.jhep.2021.04.048] [Reference Citation Analysis]
62 Sato T, Semura K, Fujimoto I. Micro‑dimpled surface atelocollagen maintains primary human hepatocytes in culture and may promote their functionality compared with collagen coat culture. Int J Mol Med 2019;44:960-72. [PMID: 31257473 DOI: 10.3892/ijmm.2019.4251] [Reference Citation Analysis]
63 Pasqua M, Di Gesù R, Chinnici CM, Conaldi PG, Francipane MG. Generation of Hepatobiliary Cell Lineages from Human Induced Pluripotent Stem Cells: Applications in Disease Modeling and Drug Screening. Int J Mol Sci 2021;22:8227. [PMID: 34360991 DOI: 10.3390/ijms22158227] [Reference Citation Analysis]
64 Zhong Y, Yu JS, Wang X, Binas B, Yoo HH. Chemical-based primary human hepatocyte monolayer culture for the study of drug metabolism and hepatotoxicity: Comparison with the spheroid model. FASEB J 2021;35:e21379. [PMID: 33566373 DOI: 10.1096/fj.202001629RR] [Reference Citation Analysis]
65 Seo JE, Davis K, Malhi P, He X, Bryant M, Talpos J, Burks S, Mei N, Guo X. Genotoxicity evaluation using primary hepatocytes isolated from rhesus macaque (Macaca mulatta). Toxicology 2021;462:152936. [PMID: 34509578 DOI: 10.1016/j.tox.2021.152936] [Reference Citation Analysis]
66 Silva B, Rodrigues JS, Almeida AS, Lima AR, Fernandes C, de Pinho PG, Miranda JP, Remião F. Enantioselectivity of Pentedrone and Methylone on Metabolic Profiling in 2D and 3D Human Hepatocyte-like Cells. Pharmaceuticals 2022;15:368. [DOI: 10.3390/ph15030368] [Reference Citation Analysis]
67 Noorlander A, Fabian E, van Ravenzwaay B, Rietjens IMCM. Novel testing strategy for prediction of rat biliary excretion of intravenously administered estradiol-17β glucuronide. Arch Toxicol 2021;95:91-102. [PMID: 33159584 DOI: 10.1007/s00204-020-02908-x] [Reference Citation Analysis]
68 Padberg F, Hering H, Luch A, Zellmer S. Indirect co-cultivation of HepG2 with differentiated THP-1 cells induces AHR signalling and release of pro-inflammatory cytokines. Toxicol In Vitro 2020;68:104957. [PMID: 32739440 DOI: 10.1016/j.tiv.2020.104957] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
69 Chapuy-regaud S, Allioux C, Capelli N, Migueres M, Lhomme S, Izopet J. Vectorial Release of Human RNA Viruses from Epithelial Cells. Viruses 2022;14:231. [DOI: 10.3390/v14020231] [Reference Citation Analysis]
70 Allameh A, Ahmadi-Ashtiani HR, Maleki N. Glutathione-related inflammatory signature in hepatocytes differentiated from the progenitor mesenchymal stem cells. Heliyon 2020;6:e04149. [PMID: 32551386 DOI: 10.1016/j.heliyon.2020.e04149] [Reference Citation Analysis]
71 Barreto A, Carvalho A, Silva D, Pinto E, Almeida A, Paíga P, Correira-Sá L, Delerue-Matos C, Trindade T, Soares AMVM, Hylland K, Loureiro S, Oliveira M. Effects of single and combined exposures of gold (nano versus ionic form) and gemfibrozil in a liver organ culture of Sparus aurata. Mar Pollut Bull 2020;160:111665. [PMID: 33181940 DOI: 10.1016/j.marpolbul.2020.111665] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
72 Harada K, Kohara H, Yukawa T, Matsumiya K, Shinozawa T. Cell-based high-throughput screening for the evaluation of reactive metabolite formation potential. Toxicol In Vitro 2021;74:105159. [PMID: 33823239 DOI: 10.1016/j.tiv.2021.105159] [Reference Citation Analysis]
73 Jellali R, Lereau Bernier M, Tauran Y, Gilard F, Danoy M, Kido T, Miyajima A, Sakai Y, Leclerc E. Metabolomic profiling during the differentiation of human induced pluripotent stem cells into hepatocyte-like cells. Differentiation 2020;112:17-26. [PMID: 31869687 DOI: 10.1016/j.diff.2019.10.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
74 Segovia-zafra A, Di Zeo-sánchez DE, López-gómez C, Pérez-valdés Z, García-fuentes E, Andrade RJ, Lucena MI, Villanueva-paz M. Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction. Acta Pharmaceutica Sinica B 2021;11:3685-726. [DOI: 10.1016/j.apsb.2021.11.013] [Reference Citation Analysis]
75 Liaw C, Ji S, Guvendiren M. Engineering 3D Hydrogels for Personalized In Vitro Human Tissue Models. Adv Healthcare Mater 2018;7:1701165. [DOI: 10.1002/adhm.201701165] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 10.8] [Reference Citation Analysis]
76 Marcinkiewicz C, Lelkes PI, Sternberg M, Feuerstein GZ. Effects of Fluorescent Diamond Particles FDP-NV-800nm on Essential Biochemical Functions of Primary Human Umbilical Vein Cells and Human Hepatic Cell Line, HepG-2 in vitro (Part VI): Acute Biocompatibility Studies. Nanotechnol Sci Appl 2020;13:103-18. [PMID: 33116443 DOI: 10.2147/NSA.S268107] [Reference Citation Analysis]
77 Aravalli RN, Steer CJ. Utility of Common Marmoset (Callithrix jacchus) Embryonic Stem Cells in Liver Disease Modeling, Tissue Engineering and Drug Metabolism. Genes (Basel) 2020;11:E729. [PMID: 32630053 DOI: 10.3390/genes11070729] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
78 Østbye TK, Berge GM, Nilsson A, Romarheim OH, Bou M, Ruyter B. The long-chain monounsaturated cetoleic acid improves the efficiency of the n-3 fatty acid metabolic pathway in Atlantic salmon and human HepG2 cells. Br J Nutr 2019;122:755-68. [PMID: 31288871 DOI: 10.1017/S0007114519001478] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
79 Parafati M, Kirby RJ, Khorasanizadeh S, Rastinejad F, Malany S. A nonalcoholic fatty liver disease model in human induced pluripotent stem cell-derived hepatocytes, created by endoplasmic reticulum stress-induced steatosis. Dis Model Mech 2018;11:dmm033530. [PMID: 30254132 DOI: 10.1242/dmm.033530] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 6.5] [Reference Citation Analysis]
80 Guvenc D, Inal S, Kuruca N, Gokmen S, Guvenc T. Synthetic pyrethroids common metabolite 3-phenoxybenzoic acid induces caspase-3 and Bcl-2 mediated apoptosis in human hepatocyte cells. Drug Chem Toxicol 2021;:1-7. [PMID: 33706615 DOI: 10.1080/01480545.2021.1894720] [Reference Citation Analysis]
81 Tutty MA, Movia D, Prina-Mello A. Three-dimensional (3D) liver cell models - a tool for bridging the gap between animal studies and clinical trials when screening liver accumulation and toxicity of nanobiomaterials. Drug Deliv Transl Res 2022. [PMID: 35507131 DOI: 10.1007/s13346-022-01147-0] [Reference Citation Analysis]
82 Sundriyal S, Chen PB, Lubin AS, Lueg GA, Li F, White AJP, Malmquist NA, Vedadi M, Scherf A, Fuchter MJ. Histone lysine methyltransferase structure activity relationships that allow for segregation of G9a inhibition and anti-Plasmodium activity. Medchemcomm 2017;8:1069-92. [PMID: 29308121 DOI: 10.1039/c7md00052a] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 2.8] [Reference Citation Analysis]
83 Naito Y, Yoshinouchi Y, Sorayama Y, Kohara H, Kitano S, Irie S, Matsusaki M. Constructing vascularized hepatic tissue by cell-assembled viscous tissue sedimentation method and its application for vascular toxicity assessment. Acta Biomater 2021:S1742-7061(21)00775-3. [PMID: 34826641 DOI: 10.1016/j.actbio.2021.11.027] [Reference Citation Analysis]
84 Lőrincz T, Deák V, Makk-Merczel K, Varga D, Hajdinák P, Szarka A. The Performance of HepG2 and HepaRG Systems through the Glass of Acetaminophen-Induced Toxicity. Life (Basel) 2021;11:856. [PMID: 34440600 DOI: 10.3390/life11080856] [Reference Citation Analysis]
85 Azparren-Angulo M, Royo F, Gonzalez E, Liebana M, Brotons B, Berganza J, Goñi-de-Cerio F, Manicardi N, Abad-Jordà L, Gracia-Sancho J, Falcon-Perez JM. Extracellular vesicles in hepatology: Physiological role, involvement in pathogenesis, and therapeutic opportunities. Pharmacol Ther 2021;218:107683. [PMID: 32961265 DOI: 10.1016/j.pharmthera.2020.107683] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
86 Hurrell T, Naidoo J, Scholefield J. Hepatic Models in Precision Medicine: An African Perspective on Pharmacovigilance. Front Genet 2022;13:864725. [DOI: 10.3389/fgene.2022.864725] [Reference Citation Analysis]
87 Neo S, Makiishi E, Fujimoto A, Hisasue M. Human placental hydrolysate promotes the long-term culture of hepatocyte-like cells derived from canine bone marrow. J Vet Med Sci 2021;82:1821-7. [PMID: 33132358 DOI: 10.1292/jvms.20-0320] [Reference Citation Analysis]
88 Tasnim F, Huang X, Lee CZW, Ginhoux F, Yu H. Recent Advances in Models of Immune-Mediated Drug-Induced Liver Injury. Front Toxicol 2021;3:605392. [PMID: 35295156 DOI: 10.3389/ftox.2021.605392] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
89 Herrera-Balandrano DD, Chai Z, Hutabarat RP, Beta T, Feng J, Ma K, Li D, Huang W. Hypoglycemic and hypolipidemic effects of blueberry anthocyanins by AMPK activation: In vitro and in vivo studies. Redox Biol 2021;46:102100. [PMID: 34416477 DOI: 10.1016/j.redox.2021.102100] [Reference Citation Analysis]
90 Malik M, Yang Y, Fathi P, Mahler GJ, Esch MB. Critical Considerations for the Design of Multi-Organ Microphysiological Systems (MPS). Front Cell Dev Biol 2021;9:721338. [PMID: 34568333 DOI: 10.3389/fcell.2021.721338] [Reference Citation Analysis]
91 Lin X, Tang J, Lou YR. Human Pluripotent Stem-Cell-Derived Models as a Missing Link in Drug Discovery and Development. Pharmaceuticals (Basel) 2021;14:525. [PMID: 34070895 DOI: 10.3390/ph14060525] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
92 Wei J, Lei D, Chen M, Ran P, Li X. Engineering HepG2 spheroids with injectable fiber fragments as predictable models for drug metabolism and tumor infiltration. J Biomed Mater Res B Appl Biomater 2020;108:3331-44. [PMID: 32627303 DOI: 10.1002/jbm.b.34669] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
93 Abbott A, Coburn JM. HepaRG Maturation in Silk Fibroin Scaffolds: Toward Developing a 3D In Vitro Liver Model. ACS Biomater Sci Eng 2021. [PMID: 34105934 DOI: 10.1021/acsbiomaterials.0c01584] [Reference Citation Analysis]
94 Jiang J, Pieterman CD, Ertaylan G, Peeters RLM, de Kok TMCM. The application of omics-based human liver platforms for investigating the mechanism of drug-induced hepatotoxicity in vitro. Arch Toxicol 2019;93:3067-98. [PMID: 31586243 DOI: 10.1007/s00204-019-02585-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
95 Boeri L, Izzo L, Sardelli L, Tunesi M, Albani D, Giordano C. Advanced Organ-on-a-Chip Devices to Investigate Liver Multi-Organ Communication: Focus on Gut, Microbiota and Brain. Bioengineering (Basel) 2019;6:E91. [PMID: 31569428 DOI: 10.3390/bioengineering6040091] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]